461 related articles for article (PubMed ID: 12541180)
41. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
Nomura K; Yamanouchi T
J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639
[TBL] [Abstract][Full Text] [Related]
42. [Nonalcoholic steatohepatitis].
da Silva PM; Eliseu T; Costa MM; Bastos H; Nobre FL
Acta Med Port; 1995 May; 8(5):323-7. PubMed ID: 7625233
[TBL] [Abstract][Full Text] [Related]
43. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
44. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
45. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
Mori S; Yamasaki T; Sakaida I; Takami T; Sakaguchi E; Kimura T; Kurokawa F; Maeyama S; Okita K
J Gastroenterol; 2004; 39(4):391-6. PubMed ID: 15168253
[TBL] [Abstract][Full Text] [Related]
46. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
47. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
Carter-Kent C; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
[TBL] [Abstract][Full Text] [Related]
48. Nonalcoholic steatohepatitis--a histological perspective.
Sakhuja P; Malhotra V
Indian J Pathol Microbiol; 2006 Apr; 49(2):163-72. PubMed ID: 16933708
[TBL] [Abstract][Full Text] [Related]
49. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
50. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
Nugent C; Younossi ZM
Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
[TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.
Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
Clin Biochem; 2005 Mar; 38(3):203-17. PubMed ID: 15708540
[TBL] [Abstract][Full Text] [Related]
52. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
Anderson N; Borlak J
Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
[TBL] [Abstract][Full Text] [Related]
53. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
Oh MK; Winn J; Poordad F
Aliment Pharmacol Ther; 2008 Sep; 28(5):503-22. PubMed ID: 18532991
[TBL] [Abstract][Full Text] [Related]
54. Pathogenesis of NASH: animal models.
London RM; George J
Clin Liver Dis; 2007 Feb; 11(1):55-74, viii. PubMed ID: 17544972
[TBL] [Abstract][Full Text] [Related]
55. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
Boppidi H; Daram SR
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
[TBL] [Abstract][Full Text] [Related]
56. Natural history of nonalcoholic steatohepatitis.
Liou I; Kowdley KV
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
[TBL] [Abstract][Full Text] [Related]
57. The emerging problem of nonalcoholic steatohepatitis (NASH).
Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of non-alcoholic fatty liver disease].
Koek GH
Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
[TBL] [Abstract][Full Text] [Related]
59. [Nonalcoholic steatohepatitis in children].
Cubelić S; Misak Z; Gasparov S; Kolacek S
Lijec Vjesn; 2004; 126(7-8):197-200. PubMed ID: 15754789
[TBL] [Abstract][Full Text] [Related]
60. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
Cusi K
Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
